Skip to main content
Premium Trial:

Request an Annual Quote

Arzu Selen, Vivien Bonazzi, Colette Saccomanno, Jake Orville, Geoff Alms, Greg Herrema, David Weber, Mark Beck

Arzu Selen joined FDA’s Office of New Drug Quality Assessment as the Associate Director for Biopharmaceutics, FDA announced. She will be the principal advisor to ONDQA on policy matters and programs for assessing drug release specifications or dissolution and quality-by-design issues.
Selen joined the FDA’s Office of Clinical Pharmacology in 1997, where most recently she was the deputy division director of the Division of Clinical Pharmacology IV in the Office of Clinical Pharmacology. She has also held positions in the pharmaceutical industry with Parke-Davis and Zeneca Pharmaceuticals and was director of pharmacokinetics for Alkermes.

Gene Express has appointed Colette Saccomanno to be the company's director of business development, the company said last week.
Saccomanno, who has a sales and marketing background, most recently was program manager at ArisGlobal and was a senior account executive at Galt Associates. She also served as account executive at Covance Laboratories' Early Development segment, which is now Abbott Molecular, and at Bio-Rad Laboratories.

NextGen has appointed Jake Orville as vice president of global sales, the company said last week.
Orville comes to NextGen from Third Wave Technologies, where he was vice president of sales and business development.
Orville takes over for Geoff Alms, who moves to a lead role in North American development.

The Personalized Medicine Coalition this week awarded Elizabeth Nabel, director of the National Heart, Lung, and Blood Institute, its 2006 Leadership in Personalized Medicine Award “for her insights into the molecular basis of cardiovascular disease and her leadership in steering those advances into clinical practice on a national scale,” the PMC said in a statement.

At the helm of the NHLBI, Nabel “champions the exploration of the genetics in large-scale population studies,” the PMC said, including the Women's Health Initiative. Also, in February she helped launch a genetic study as part of the Framingham Heart Study. Her addition, called the Framingham Genetic Research Study, seeks to identify genes underlying cardiovascular and other chronic diseases.

Filed under

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.